Molecule Holdings Inc. (EVRRF) Stock Price & Growth Analysis

Quote Panel

Updated August 15, 2025

1W 0.00 % 1M 0.00 % 3M 0.00 % 1Y 0.00 %

Key Metrics

Market Cap
887.95M
Shares Outstanding
355.18B
Share in Float
286.66B
Dividende
0

Earning Date
No Data
Price Target
0.0025
Average Volume
10468.46215
Beta
-0.607

Range
0.0025-0.0025
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.molecule.ca
Sector
Healthcare

Quote Panel

Updated August 15, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

0.25x

P/S Ratio

N/Ax

P/B Ratio

N/A

Debt/Equity

-230.8%

Net Margin

$-0.0

EPS

How EVRRF compares to sector?

P/E Ratio

Fundamentals

Relative Strength

EVRRF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

EVRRF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

N/A

2025-Revenue

N/A

2025-EPS

N/A

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q2.21

N/A

-0.01
vs NA

Q3.21

N/A

-0.01
vs NA

Q4.21

N/A

-0.01
vs NA

Q1.22

N/A

-0.01
vs -0.01

Q2.22

N/A

-0.01
vs -0.01

Q3.22

N/A

-0.01
vs -0.01

Q4.22

N/A

-0.02
vs -0.01

Q1.23

N/A

-0.01
vs -0.01

Q2.23

N/A

-0.01
vs -0.01

Q3.23

N/A

-0.01
vs -0.01

Sales Growth

YoY

Current

Estimates

Q2.21

68.5K vs NA

Q3.21

254.8K vs NA

Q4.21

131.9K vs NA

Q1.22

259.9K vs NA

Q2.22

+548%

443.8K vs 68.5K

Q3.22

+197%

758K vs 254.8K

Q4.22

+284%

506.6K vs 131.9K

Q1.23

+51%

391.4K vs 259.9K

Q2.23

-62%

166.9K vs 443.8K

Q3.23

-6%

714.3K vs 758K

Return on Equity

QoQ

Q2.21

-48%

-0.48
vs -0.28

Q3.21

-43%

-0.43
vs -0.48

Q4.21

-192%

-1.92
vs -0.43

Q1.22

+232%

2.32
vs -1.92

Q2.22

+69%

0.69
vs 2.32

Q3.22

+46%

0.46
vs 0.69

Q4.22

+40%

0.4
vs 0.46

Q1.23

+16%

0.16
vs 0.4

Q2.23

+18%

0.18
vs 0.16

Q3.23

+14%

0.14
vs 0.18

Institutionnal Ownership

N/A

Q2.23

NA
vs NA

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q2.21

N/A

-0.01
vs NA

Q3.21

N/A

-0.01
vs NA

Q4.21

N/A

-0.01
vs NA

Q1.22

N/A

-0.01
vs -0.01

Q2.22

N/A

-0.01
vs -0.01

Q3.22

N/A

-0.01
vs -0.01

Q4.22

N/A

-0.02
vs -0.01

Q1.23

N/A

-0.01
vs -0.01

Q2.23

N/A

-0.01
vs -0.01

Q3.23

N/A

-0.01
vs -0.01

Sales Growth

YoY

Current

Estimates

Q2.21

68.5K vs NA

Q3.21

254.8K vs NA

Q4.21

131.9K vs NA

Q1.22

259.9K vs NA

Q2.22

+548%

443.8K vs 68.5K

Q3.22

+197%

758K vs 254.8K

Q4.22

+284%

506.6K vs 131.9K

Q1.23

+51%

391.4K vs 259.9K

Q2.23

-62%

166.9K vs 443.8K

Q3.23

-6%

714.3K vs 758K

Return on Equity

QoQ

Q2.21

-48%

-0.48
vs -0.28

Q3.21

-43%

-0.43
vs -0.48

Q4.21

-192%

-1.92
vs -0.43

Q1.22

+232%

2.32
vs -1.92

Q2.22

+69%

0.69
vs 2.32

Q3.22

+46%

0.46
vs 0.69

Q4.22

+40%

0.4
vs 0.46

Q1.23

+16%

0.16
vs 0.4

Q2.23

+18%

0.18
vs 0.16

Q3.23

+14%

0.14
vs 0.18

Institutionnal Ownership

N/A

Q2.23

NA
vs NA

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Company Description

0.00USD

N/A

0.25x

N/Ax

N/A

-230.8%

$-0.0

N/A

N/A

N/A

Earnings Growth

Latest News

Latest News

Latest News

Earnings Growth

N/A

N/A

N/A

Company Description

0.00USD

N/A

0.25x

N/Ax

N/A

-230.8%

$-0.0